Global Equine Pharmaceuticals and Supplements Competitive Landscape Professional Research Report 2025
Market Overview
According to DIResearch's in-depth investigation and research, the global Equine Pharmaceuticals and Supplements market size will reach 1,385.51 Million USD in 2025 and is projected to reach 1,967.82 Million USD by 2032, with a CAGR of 5.14% (2025-2032). Notably, the China Equine Pharmaceuticals and Supplements market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Equine pharmaceuticals and supplements refer to a category of products specifically developed for the health and well-being of horses. These include a wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements are typically non-prescription products used to support overall health, performance, and specific nutritional requirements. Common equine supplements include vitamins, minerals, joint supplements, digestive aids, and herbal remedies. The use of equine pharmaceuticals and supplements is essential in maintaining the health, performance, and longevity of horses, and their application can vary widely based on the individual horse's needs, activity level, and health conditions. These products are an integral part of modern equine healthcare and management.
The major global manufacturers of Equine Pharmaceuticals and Supplements include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Equine Pharmaceuticals and Supplements. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Equine Pharmaceuticals and Supplements market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Equine Pharmaceuticals and Supplements market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Equine Pharmaceuticals and Supplements industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Equine Pharmaceuticals and Supplements Include:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Equine Pharmaceuticals and Supplements Product Segment Include:
Saddles and accessories
Bridles & Attachments
Halters
Bits
Blankets
Protection Boots & Wraps
Hoods
Stirrups
Equine Pharmaceuticals and Supplements Product Application Include:
Children
Adults
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Equine Pharmaceuticals and Supplements Industry PESTEL Analysis
Chapter 3: Global Equine Pharmaceuticals and Supplements Industry Porter’s Five Forces Analysis
Chapter 4: Global Equine Pharmaceuticals and Supplements Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Equine Pharmaceuticals and Supplements Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Equine Pharmaceuticals and Supplements Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Equine Pharmaceuticals and Supplements market size will reach 1,385.51 Million USD in 2025 and is projected to reach 1,967.82 Million USD by 2032, with a CAGR of 5.14% (2025-2032). Notably, the China Equine Pharmaceuticals and Supplements market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Equine pharmaceuticals and supplements refer to a category of products specifically developed for the health and well-being of horses. These include a wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements are typically non-prescription products used to support overall health, performance, and specific nutritional requirements. Common equine supplements include vitamins, minerals, joint supplements, digestive aids, and herbal remedies. The use of equine pharmaceuticals and supplements is essential in maintaining the health, performance, and longevity of horses, and their application can vary widely based on the individual horse's needs, activity level, and health conditions. These products are an integral part of modern equine healthcare and management.
The major global manufacturers of Equine Pharmaceuticals and Supplements include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Equine Pharmaceuticals and Supplements. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Equine Pharmaceuticals and Supplements market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Equine Pharmaceuticals and Supplements market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Equine Pharmaceuticals and Supplements industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Equine Pharmaceuticals and Supplements Include:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Equine Pharmaceuticals and Supplements Product Segment Include:
Saddles and accessories
Bridles & Attachments
Halters
Bits
Blankets
Protection Boots & Wraps
Hoods
Stirrups
Equine Pharmaceuticals and Supplements Product Application Include:
Children
Adults
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Equine Pharmaceuticals and Supplements Industry PESTEL Analysis
Chapter 3: Global Equine Pharmaceuticals and Supplements Industry Porter’s Five Forces Analysis
Chapter 4: Global Equine Pharmaceuticals and Supplements Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Equine Pharmaceuticals and Supplements Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Equine Pharmaceuticals and Supplements Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
1 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OVERVIEW
1.1 Product Definition and Statistical Scope
1.2 Equine Pharmaceuticals and Supplements Product by Type
1.2.1 Saddles and accessories
1.2.2 Bridles & Attachments
1.2.3 Halters
1.2.4 Bits
1.2.5 Blankets
1.2.6 Protection Boots & Wraps
1.2.7 Hoods
1.2.8 Stirrups
1.3 Equine Pharmaceuticals and Supplements Product by Application
1.3.1 Children
1.3.2 Adults
1.4 Global Equine Pharmaceuticals and Supplements Market Revenue and Sales Analysis
1.4.1 Global Equine Pharmaceuticals and Supplements Revenue Market Size Analysis (2020-2032)
1.4.2 Global Equine Pharmaceuticals and Supplements Sales Market Size Analysis (2020-2032)
1.4.3 Global Equine Pharmaceuticals and Supplements Market Sales Price Trend Analysis (2020-2032)
1.5 Equine Pharmaceuticals and Supplements Industry Trends and Innovation
1.5.1 Equine Pharmaceuticals and Supplements Industry Trends and Innovation
1.5.2 Equine Pharmaceuticals and Supplements Market Drivers and Challenges
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET ANALYSIS BY REGIONS
4.1 Global Equine Pharmaceuticals and Supplements Overall Market: 2024 VS 2025 VS 2032
4.2 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Region (2020-2025)
4.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2026-2032)
4.3 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis (2020-2032)
4.3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Region (2020-2025)
4.3.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2032)
4.4 Global Equine Pharmaceuticals and Supplements Sales Price Trend Analysis (2020-2032)
5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Equine Pharmaceuticals and Supplements Market Size by Type
5.1.1 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis by Type (2020-2032)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis by Type (2020-2032)
5.2 Global Equine Pharmaceuticals and Supplements Market Size by Application
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis by Application (2020-2032)
5.2.2 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Equine Pharmaceuticals and Supplements Market Size by Type
6.3.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
6.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
6.4 North America Equine Pharmaceuticals and Supplements Market Size by Application
6.4.1 North America Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
6.4.2 North America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
6.5 North America Equine Pharmaceuticals and Supplements Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Equine Pharmaceuticals and Supplements Market Size by Type
7.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
7.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
7.4 Europe Equine Pharmaceuticals and Supplements Market Size by Application
7.4.1 Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
7.4.2 Europe Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
7.5 Europe Equine Pharmaceuticals and Supplements Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Equine Pharmaceuticals and Supplements Market Size by Type
8.3.1 China Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
8.3.2 China Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
8.4 China Equine Pharmaceuticals and Supplements Market Size by Application
8.4.1 China Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
8.4.2 China Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Type
9.3.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
9.3.2 APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
9.4 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Application
9.4.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
9.4.2 APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
9.5 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Equine Pharmaceuticals and Supplements Market Size by Type
10.3.1 Latin America Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
10.3.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
10.4 Latin America Equine Pharmaceuticals and Supplements Market Size by Application
10.4.1 Latin America Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
10.4.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
10.5 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
10.6 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
10.6.1 Mexico
10.6.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Type
11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
11.4 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Application
11.4.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
11.4.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
11.5 Middle East Equine Pharmaceuticals and Supplements Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY MANUFACTURERS
12.1 Global Equine Pharmaceuticals and Supplements Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
12.1.1 Global Equine Pharmaceuticals and Supplements Market Sales by Key Manufacturers (2021-2025)
12.1.2 Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025)
12.1.3 Global Equine Pharmaceuticals and Supplements Average Sales Price by Manufacturers (2021-2025)
12.2 Equine Pharmaceuticals and Supplements Competitive Landscape Analysis and Market Dynamic
12.2.1 Equine Pharmaceuticals and Supplements Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.2 Merck Animal Health
13.2.1 Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.3 Zoetis
13.3.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
13.3.3 Zoetis Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.4 Bayer Animal Health
13.4.1 Bayer Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.7 CEVA
13.7.1 CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
13.7.3 CEVA Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.8 Virbac
13.8.1 Virbac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
13.8.3 Virbac Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.9 Norbrook Equine
13.9.1 Norbrook Equine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.10 Kyoritsu Seiyaku
13.10.1 Kyoritsu Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.11 Vetoquinol
13.11.1 Vetoquinol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.12 Protexin Healthcare
13.12.1 Protexin Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.13 Audevard
13.13.1 Audevard Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
13.13.3 Audevard Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.14 Ouro Fino Saude
13.14.1 Ouro Fino Saude Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
14.2 Equine Pharmaceuticals and Supplements Industry Raw Material and Suppliers Analysis
14.2.1 Equine Pharmaceuticals and Supplements Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Equine Pharmaceuticals and Supplements Typical Downstream Customers
14.4 Equine Pharmaceuticals and Supplements Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
1.1 Product Definition and Statistical Scope
1.2 Equine Pharmaceuticals and Supplements Product by Type
1.2.1 Saddles and accessories
1.2.2 Bridles & Attachments
1.2.3 Halters
1.2.4 Bits
1.2.5 Blankets
1.2.6 Protection Boots & Wraps
1.2.7 Hoods
1.2.8 Stirrups
1.3 Equine Pharmaceuticals and Supplements Product by Application
1.3.1 Children
1.3.2 Adults
1.4 Global Equine Pharmaceuticals and Supplements Market Revenue and Sales Analysis
1.4.1 Global Equine Pharmaceuticals and Supplements Revenue Market Size Analysis (2020-2032)
1.4.2 Global Equine Pharmaceuticals and Supplements Sales Market Size Analysis (2020-2032)
1.4.3 Global Equine Pharmaceuticals and Supplements Market Sales Price Trend Analysis (2020-2032)
1.5 Equine Pharmaceuticals and Supplements Industry Trends and Innovation
1.5.1 Equine Pharmaceuticals and Supplements Industry Trends and Innovation
1.5.2 Equine Pharmaceuticals and Supplements Market Drivers and Challenges
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET ANALYSIS BY REGIONS
4.1 Global Equine Pharmaceuticals and Supplements Overall Market: 2024 VS 2025 VS 2032
4.2 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Region (2020-2025)
4.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2026-2032)
4.3 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis (2020-2032)
4.3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Region (2020-2025)
4.3.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2032)
4.4 Global Equine Pharmaceuticals and Supplements Sales Price Trend Analysis (2020-2032)
5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Equine Pharmaceuticals and Supplements Market Size by Type
5.1.1 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis by Type (2020-2032)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis by Type (2020-2032)
5.2 Global Equine Pharmaceuticals and Supplements Market Size by Application
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue and Forecast Analysis by Application (2020-2032)
5.2.2 Global Equine Pharmaceuticals and Supplements Sales and Forecast Analysis by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Equine Pharmaceuticals and Supplements Market Size by Type
6.3.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
6.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
6.4 North America Equine Pharmaceuticals and Supplements Market Size by Application
6.4.1 North America Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
6.4.2 North America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
6.5 North America Equine Pharmaceuticals and Supplements Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Equine Pharmaceuticals and Supplements Market Size by Type
7.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
7.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
7.4 Europe Equine Pharmaceuticals and Supplements Market Size by Application
7.4.1 Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
7.4.2 Europe Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
7.5 Europe Equine Pharmaceuticals and Supplements Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Equine Pharmaceuticals and Supplements Market Size by Type
8.3.1 China Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
8.3.2 China Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
8.4 China Equine Pharmaceuticals and Supplements Market Size by Application
8.4.1 China Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
8.4.2 China Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Type
9.3.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
9.3.2 APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
9.4 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Application
9.4.1 APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
9.4.2 APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
9.5 APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Equine Pharmaceuticals and Supplements Market Size by Type
10.3.1 Latin America Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
10.3.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
10.4 Latin America Equine Pharmaceuticals and Supplements Market Size by Application
10.4.1 Latin America Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
10.4.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
10.5 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
10.6 Latin America Equine Pharmaceuticals and Supplements Market Size by Country
10.6.1 Mexico
10.6.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Type
11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2032)
11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2020-2032)
11.4 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Application
11.4.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2032)
11.4.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2020-2032)
11.5 Middle East Equine Pharmaceuticals and Supplements Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY MANUFACTURERS
12.1 Global Equine Pharmaceuticals and Supplements Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
12.1.1 Global Equine Pharmaceuticals and Supplements Market Sales by Key Manufacturers (2021-2025)
12.1.2 Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025)
12.1.3 Global Equine Pharmaceuticals and Supplements Average Sales Price by Manufacturers (2021-2025)
12.2 Equine Pharmaceuticals and Supplements Competitive Landscape Analysis and Market Dynamic
12.2.1 Equine Pharmaceuticals and Supplements Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.2 Merck Animal Health
13.2.1 Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.3 Zoetis
13.3.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
13.3.3 Zoetis Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.4 Bayer Animal Health
13.4.1 Bayer Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.5 Elanco Animal Health
13.5.1 Elanco Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.7 CEVA
13.7.1 CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
13.7.3 CEVA Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.8 Virbac
13.8.1 Virbac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
13.8.3 Virbac Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.9 Norbrook Equine
13.9.1 Norbrook Equine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.10 Kyoritsu Seiyaku
13.10.1 Kyoritsu Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.11 Vetoquinol
13.11.1 Vetoquinol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.12 Protexin Healthcare
13.12.1 Protexin Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.13 Audevard
13.13.1 Audevard Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
13.13.3 Audevard Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.14 Ouro Fino Saude
13.14.1 Ouro Fino Saude Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
14.2 Equine Pharmaceuticals and Supplements Industry Raw Material and Suppliers Analysis
14.2.1 Equine Pharmaceuticals and Supplements Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Equine Pharmaceuticals and Supplements Typical Downstream Customers
14.4 Equine Pharmaceuticals and Supplements Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
LIST OF TABLES
Table 1: Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Equine Pharmaceuticals and Supplements Industry Development Status
Table 4: Equine Pharmaceuticals and Supplements Industry Development Trends
Table 5: Global Equine Pharmaceuticals and Supplements Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 8: Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Unit)
Table 11: Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 12: Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2032) & (K Unit)
Table 13: Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2026-2032)
Table 14: Global Equine Pharmaceuticals and Supplements Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 15: Global Equine Pharmaceuticals and Supplements Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 16: Global Equine Pharmaceuticals and Supplements Sales Analysis by Type (2020-2025) & (K Unit)
Table 17: Global Equine Pharmaceuticals and Supplements Sales Analysis Forecast by Type (2026-2032) & (K Unit)
Table 18: Global Equine Pharmaceuticals and Supplements Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 19: Global Equine Pharmaceuticals and Supplements Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 20: Global Equine Pharmaceuticals and Supplements Sales Analysis by Application (2020-2025) & (K Unit)
Table 21: Global Equine Pharmaceuticals and Supplements Sales Analysis Forecast by Application (2026-2032) & (K Unit)
Table 22: Key Equine Pharmaceuticals and Supplements Players in North America
Table 23: North America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 24: North America Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 25: North America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 26: North America Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 27: North America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 28: North America Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 29: North America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 30: North America Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 31: North America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 32: North America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 33: North America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 34: North America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2026-2032) & (K Unit)
Table 35: Key Equine Pharmaceuticals and Supplements Players in Europe
Table 36: Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 37: Europe Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 38: Europe Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 39: Europe Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 40: Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 41: Europe Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 42: Europe Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 43: Europe Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 44: Europe Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 45: Europe Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 46: Europe Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 47: Europe Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 48: Key Equine Pharmaceuticals and Supplements Players in China
Table 49: China Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 50: China Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 51: China Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 52: China Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 53: China Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 54: China Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 55: China Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 56: China Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 57: Key Equine Pharmaceuticals and Supplements Players in APAC (excl. China)
Table 58: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 59: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 60: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 61: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 62: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 63: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 64: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 65: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 66:: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 67: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 68: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 69: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 70: Key Equine Pharmaceuticals and Supplements Players in Latin America
Table 71: Latin America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 72: Latin America Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 73: Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 74: Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 75: Latin America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 76: Latin America Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 77: Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 78: Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 79: Latin America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 80: Latin America Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 81: Latin America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 82: Latin America Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 83: Key Equine Pharmaceuticals and Supplements Players in Middle East & Africa
Table 84: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 85: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 86: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 87: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 88: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 89: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 90: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 91: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 92: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 93: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 94: Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 95: Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 96: Global Equine Pharmaceuticals and Supplements Market Sales by Key Manufacturers (2021-2025) & (K Unit)
Table 97: Global Equine Pharmaceuticals and Supplements Sales Market Share by Key Manufacturers (2021-2025)
Table 98: Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025) & (US$ Million)
Table 99: Global Equine Pharmaceuticals and Supplements Revenue Market Share by Key Manufacturers (2021-2025)
Table 100: Global Average Sales Price by Manufacturers (2021-2025) & (USD/Unit)
Table 101: Global Key Manufacturers Headquarter Location and Key Area Sales
Table 102: Market Mergers & Acquisitions, Expansion
Table 103: Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 104: Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
Table 105: Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 106: Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 107: Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 108: Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 109: Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 110: Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
Table 111: Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 112: Bayer Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 113: Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 114: Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 115: Elanco Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 116: Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 117: Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 118: Dechra Veterinary Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 119: Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
Table 120: Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 121: CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 122: CEVA Equine Pharmaceuticals and Supplements Product Portfolio
Table 123: CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 124: Virbac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 125: Virbac Equine Pharmaceuticals and Supplements Product Portfolio
Table 126: Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 127: Norbrook Equine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 128: Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
Table 129: Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 130: Kyoritsu Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 131: Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
Table 132: Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 133: Vetoquinol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 134: Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
Table 135: Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 136: Protexin Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 137: Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
Table 138: Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 139: Audevard Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 140: Audevard Equine Pharmaceuticals and Supplements Product Portfolio
Table 141: Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 142: Ouro Fino Saude Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 143: Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
Table 144: Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 145: Upstream Key Raw Material Price List
Table 146: Equine Pharmaceuticals and Supplements Raw Material Suppliers and Contact Information
Table 147: Equine Pharmaceuticals and Supplements Typical Customer List
Table 148: Equine Pharmaceuticals and Supplements Distributors List
Table 1: Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Equine Pharmaceuticals and Supplements Industry Development Status
Table 4: Equine Pharmaceuticals and Supplements Industry Development Trends
Table 5: Global Equine Pharmaceuticals and Supplements Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 8: Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Unit)
Table 11: Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 12: Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2032) & (K Unit)
Table 13: Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2026-2032)
Table 14: Global Equine Pharmaceuticals and Supplements Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 15: Global Equine Pharmaceuticals and Supplements Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 16: Global Equine Pharmaceuticals and Supplements Sales Analysis by Type (2020-2025) & (K Unit)
Table 17: Global Equine Pharmaceuticals and Supplements Sales Analysis Forecast by Type (2026-2032) & (K Unit)
Table 18: Global Equine Pharmaceuticals and Supplements Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 19: Global Equine Pharmaceuticals and Supplements Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 20: Global Equine Pharmaceuticals and Supplements Sales Analysis by Application (2020-2025) & (K Unit)
Table 21: Global Equine Pharmaceuticals and Supplements Sales Analysis Forecast by Application (2026-2032) & (K Unit)
Table 22: Key Equine Pharmaceuticals and Supplements Players in North America
Table 23: North America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 24: North America Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 25: North America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 26: North America Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 27: North America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 28: North America Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 29: North America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 30: North America Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 31: North America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 32: North America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 33: North America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 34: North America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2026-2032) & (K Unit)
Table 35: Key Equine Pharmaceuticals and Supplements Players in Europe
Table 36: Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 37: Europe Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 38: Europe Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 39: Europe Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 40: Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 41: Europe Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 42: Europe Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 43: Europe Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 44: Europe Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 45: Europe Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 46: Europe Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 47: Europe Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 48: Key Equine Pharmaceuticals and Supplements Players in China
Table 49: China Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 50: China Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 51: China Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 52: China Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 53: China Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 54: China Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 55: China Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 56: China Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 57: Key Equine Pharmaceuticals and Supplements Players in APAC (excl. China)
Table 58: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 59: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 60: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 61: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 62: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 63: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 64: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 65: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 66:: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 67: APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 68: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 69: APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 70: Key Equine Pharmaceuticals and Supplements Players in Latin America
Table 71: Latin America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 72: Latin America Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 73: Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 74: Latin America Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 75: Latin America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 76: Latin America Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 77: Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 78: Latin America Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 79: Latin America Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 80: Latin America Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 81: Latin America Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 82: Latin America Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 83: Key Equine Pharmaceuticals and Supplements Players in Middle East & Africa
Table 84: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Unit)
Table 85: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2026-2032) & (K Unit)
Table 86: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 87: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Type (2026-2032) & (US$ Million)
Table 88: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Unit)
Table 89: Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2026-2032) & (K Unit)
Table 90: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 91: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Application (2026-2032) & (US$ Million)
Table 92: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 93: Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Size Forecast by Country (2026-2032) & (US$ Million)
Table 94: Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Size by Country (2020-2025) & (K Unit)
Table 95: Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Size Forecast by Country (2026-2032) & (K Unit)
Table 96: Global Equine Pharmaceuticals and Supplements Market Sales by Key Manufacturers (2021-2025) & (K Unit)
Table 97: Global Equine Pharmaceuticals and Supplements Sales Market Share by Key Manufacturers (2021-2025)
Table 98: Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025) & (US$ Million)
Table 99: Global Equine Pharmaceuticals and Supplements Revenue Market Share by Key Manufacturers (2021-2025)
Table 100: Global Average Sales Price by Manufacturers (2021-2025) & (USD/Unit)
Table 101: Global Key Manufacturers Headquarter Location and Key Area Sales
Table 102: Market Mergers & Acquisitions, Expansion
Table 103: Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 104: Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
Table 105: Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 106: Merck Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 107: Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 108: Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 109: Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 110: Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
Table 111: Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 112: Bayer Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 113: Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 114: Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 115: Elanco Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 116: Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
Table 117: Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 118: Dechra Veterinary Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 119: Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
Table 120: Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 121: CEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 122: CEVA Equine Pharmaceuticals and Supplements Product Portfolio
Table 123: CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 124: Virbac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 125: Virbac Equine Pharmaceuticals and Supplements Product Portfolio
Table 126: Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 127: Norbrook Equine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 128: Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
Table 129: Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 130: Kyoritsu Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 131: Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
Table 132: Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 133: Vetoquinol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 134: Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
Table 135: Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 136: Protexin Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 137: Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
Table 138: Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 139: Audevard Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 140: Audevard Equine Pharmaceuticals and Supplements Product Portfolio
Table 141: Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 142: Ouro Fino Saude Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 143: Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
Table 144: Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million), Sales (K Unit), Price (USD/Unit), Gross Margin and Market Share (2021-2025)
Table 145: Upstream Key Raw Material Price List
Table 146: Equine Pharmaceuticals and Supplements Raw Material Suppliers and Contact Information
Table 147: Equine Pharmaceuticals and Supplements Typical Customer List
Table 148: Equine Pharmaceuticals and Supplements Distributors List
LIST OF FIGURES
Figure 1: Equine Pharmaceuticals and Supplements Product Pictures
Figure 2: Saddles and accessories Picture Scope
Figure 3: Bridles & Attachments Picture Scope
Figure 4: Halters Picture Scope
Figure 5: Bits Picture Scope
Figure 6: Blankets Picture Scope
Figure 7: Protection Boots & Wraps Picture Scope
Figure 8: Hoods Picture Scope
Figure 9: Stirrups Picture Scope
Figure 10: Children Picture Scope
Figure 11: Adults Picture Scope
Figure 12:Global Equine Pharmaceuticals and Supplements Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 13:Global Equine Pharmaceuticals and Supplements Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 14:Global Equine Pharmaceuticals and Supplements Market Sales and Growth Rate Analysis (2020-2032) &(K Unit)
Figure 15:Global Equine Pharmaceuticals and Supplements Market Price Trend Analysis (2020-2032) & (USD/Unit)
Figure 16:Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2032) & (US$ Million)
Figure 17:Global Equine Pharmaceuticals and Supplements Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 18:Global Equine Pharmaceuticals and Supplements Sales Price by Region (2020-2032) & (K Unit)
Figure 19:North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 20:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 21:North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 22:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 23:North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 24:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 25:US Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 26:Canada Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 27:Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 28:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 29:Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 30:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 31:Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 32:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 33:Germany Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 34:France Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 35:United Kingdom Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 36:Italy Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 37:Spain Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 38:Benelux Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 39:China Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 40:China Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 41:China Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 42:China Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 43:China Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 44:China Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 45:APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 46:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 47:APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 48:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 49:APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 50:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 51:Japan Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 52:South Korea Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 53:India Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 54:Australia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 55:Southeast Asia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 56:Latin America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 57:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 58:Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 59:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 60:Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 61:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 62:Mexico Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 63:Brazil Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 64:Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 65:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 66:Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 67:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 68:Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 69:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 70:Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 71:South Africa Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 72:Global Equine Pharmaceuticals and Supplements Sales Market Share by Key Manufacturers in 2024
Figure 73:Global Equine Pharmaceuticals and Supplements Revenue Market Share by Key Manufacturers in 2024
Figure 74:Global Equine Pharmaceuticals and Supplements Industry Competition Landscape
Figure 75:Equine Pharmaceuticals and Supplements Industry Chain Analysis
Figure 76:Bottom-Up and Top-Down Research Methods
Figure 77:Key Interview Objectives
Figure 78:Data Cross Validation
Figure 1: Equine Pharmaceuticals and Supplements Product Pictures
Figure 2: Saddles and accessories Picture Scope
Figure 3: Bridles & Attachments Picture Scope
Figure 4: Halters Picture Scope
Figure 5: Bits Picture Scope
Figure 6: Blankets Picture Scope
Figure 7: Protection Boots & Wraps Picture Scope
Figure 8: Hoods Picture Scope
Figure 9: Stirrups Picture Scope
Figure 10: Children Picture Scope
Figure 11: Adults Picture Scope
Figure 12:Global Equine Pharmaceuticals and Supplements Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 13:Global Equine Pharmaceuticals and Supplements Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 14:Global Equine Pharmaceuticals and Supplements Market Sales and Growth Rate Analysis (2020-2032) &(K Unit)
Figure 15:Global Equine Pharmaceuticals and Supplements Market Price Trend Analysis (2020-2032) & (USD/Unit)
Figure 16:Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2032) & (US$ Million)
Figure 17:Global Equine Pharmaceuticals and Supplements Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 18:Global Equine Pharmaceuticals and Supplements Sales Price by Region (2020-2032) & (K Unit)
Figure 19:North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 20:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 21:North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 22:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 23:North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 24:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 25:US Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 26:Canada Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 27:Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 28:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 29:Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 30:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 31:Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 32:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 33:Germany Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 34:France Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 35:United Kingdom Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 36:Italy Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 37:Spain Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 38:Benelux Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 39:China Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 40:China Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 41:China Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 42:China Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 43:China Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 44:China Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 45:APAC (excl. China) Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 46:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 47:APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 48:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 49:APAC (excl. China) Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 50:APAC (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 51:Japan Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 52:South Korea Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 53:India Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 54:Australia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 55:Southeast Asia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 56:Latin America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 57:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 58:Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 59:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 60:Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 61:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 62:Mexico Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 63:Brazil Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 64:Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 65:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Players in 2024
Figure 66:Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2032)
Figure 67:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2032)
Figure 68:Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2032)
Figure 69:Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2032)
Figure 70:Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 71:South Africa Equine Pharmaceuticals and Supplements Revenue (2020-2032) & (US$ Million)
Figure 72:Global Equine Pharmaceuticals and Supplements Sales Market Share by Key Manufacturers in 2024
Figure 73:Global Equine Pharmaceuticals and Supplements Revenue Market Share by Key Manufacturers in 2024
Figure 74:Global Equine Pharmaceuticals and Supplements Industry Competition Landscape
Figure 75:Equine Pharmaceuticals and Supplements Industry Chain Analysis
Figure 76:Bottom-Up and Top-Down Research Methods
Figure 77:Key Interview Objectives
Figure 78:Data Cross Validation
